Synchron has integrated ChatGPT into its brain implants

Synchron, known for its brain-computer interface (BCI) innovations, has announced the world's first integration of OpenAI's ChatGPT into its devices.

Here's What We Know

The move aims to improve communication for users with disabilities such as amyotrophic lateral sclerosis (ALS) patients. The artificial intelligence integration speeds up the text entry process by anticipating responses and offering the user options that can be selected with a single click. This makes communication much easier, especially for those who have difficulty typing.

Synchron CEO Tom Oxley said the release of the ChatGPT-4o, which is capable of sensing text, audio and visual input, has opened up new opportunities for BCI. The implant is expected to cost comparable to other medical devices such as pacemakers and is expected to cost between $50,000 and $100,000. Patients participating in clinical trials are already noticing an improved quality of life due to the new technology.

Go Deeper:

Synchron is a company specialising in the development of brain-computer interfaces (BCIs). Their technology allows people with disabilities to control digital devices with their thoughts. The company's main product, Stentrode, is implanted into the motor cortex of the brain through the jugular vein using a minimally invasive endovascular procedure, eliminating the need for open brain surgery. Synchron is actively working to improve the quality of life for patients with paralysis by giving them the ability to interact with computers and other devices without the use of their hands.

Source: CNET